CCPM, RGC Partner on Precision Medicine, Drug Discovery

May 18, 2020

The Colorado Center for Personalized Medicine (CCPM) and Regeneron Genetics Center (RGC) announced a new partnership aimed at using genomic data to advance precision medicine and drug discovery, Health IT Analytics reports.

According to the report, the partnership will include the sharing of 450,000 DNA samples.

“This collaboration will take an already notable program at the CCPM and expand the depth and breadth of its capabilities, allowing us to give more back to our patient participants than ever before,” CCPM Director Kathleen Barnes tells Health IT Analytics.

To read the full report, click here.

Share This Story!